Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications. - Wikidata - awgldk - TriplyDB

Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications.

Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications.

http://www.wikidata.org/entity/Q34828809

about

Recent developments in the detection and management of acute kidney injury Acute kidney injury in critically ill cancer patients: an update The cell cycle biomarkers: promising research, but do not oversell them Wnt/β-catenin signaling in kidney injury and repair: a double-edged sword Acute kidney injury: preclinical innovations, challenges, and opportunities for translation Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients Pediatric acute kidney injury: prevalence, impact and management challenges.Epidemiology of acute kidney injury in children worldwide, including developing countries.Prognostic factors and biomarkers of congenital obstructive nephropathy.Clinical significance of NGAL and KIM-1 for acute kidney injury in patients with scrub typhus.The potential utility of urinary biomarkers for risk prediction in combat casualties: a prospective observational cohort study.Molecular phenotyping of clinical AKI with novel urinary biomarkers.Heterogeneity of epigenetic changes at ischemia/reperfusion- and endotoxin-induced acute kidney injury genes.Urinary π-glutathione S-transferase Predicts Advanced Acute Kidney Injury Following Cardiovascular Surgery.High urinary excretion of kidney injury molecule-1 predicts adverse outcomes in acute kidney injury: a case control study.Biological Membrane-Packed Mesenchymal Stem Cells Treat Acute Kidney Disease by Ameliorating Mitochondrial-Related Apoptosis.Biomarkers Predicting Survival of Sepsis Patients Treated with Continuous Renal Replacement Therapy Renal Fanconi syndrome: taking a proximal look at the nephron.Issues of Acute Kidney Injury Staging and Management in Sepsis and Critical Illness: A Narrative Review.Urinary MicroRNA-30c-5p and MicroRNA-192-5p as potential biomarkers of ischemia-reperfusion-induced kidney injury.Urinary Biomarkers are Associated with Severity and Mechanism of Injury.Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.Lung-Kidney Cross-Talk in the Critically Ill Patient.Role of the intrarenal renin-angiotensin system in the progression of renal disease.Urine Interleukin 18 and Lipocalin 2 Are Biomarkers of Acute Tubular Necrosis in Patients With Cirrhosis: A Systematic Review and Meta-analysis.Differences in acute kidney injury ascertainment for clinical and preclinical studies.Biomarkers of Renal Function: Towards Clinical Actionability.Moderator's view: Patient-centered approaches for optimizing AKI management: the role of kidney biomarkers.Effect of curcumin on glycerol-induced acute kidney injury in rats.Value of plasma neutrophil gelatinase-associated lipocalin (NGAL) in distinguishing between acute kidney injury (AKI) and chronic kidney disease (CKD).How to use… serum creatinine, cystatin C and GFR.Have biomarkers failed in acute kidney injury? We are not sure.Angiotensinogen as a biomarker of acute kidney injury.Personalized physiological medicine.Real-Time and Non-invasive Monitoring of the Activation of the IRE1α-XBP1 Pathway in Individuals with Hemodynamic Impairment.Role of microRNA in the detection, progression, and intervention of acute kidney injury.Diagnostic prediction of urinary [TIMP-2] x [IGFBP7] for acute kidney injury: A meta-analysis exploring detection time and cutoff levels.Multi-scale mathematical model of drug-induced proximal tubule injury: Linking urinary biomarkers to epithelial cell injury and renal dysfunction.Urinary NGAL to define AKI in asphyxiated infants.Hyperpolarized 13 C,15 N2 -Urea MRI for assessment of the urea gradient in the porcine kidney.

P2860

Q26738725-977AC95F-EC82-4534-B53A-FFD93AFADB02 Q26740168-44EA184D-95BB-4A11-BC09-D07CBEB15264 Q26747607-5B1A18D2-1295-42FC-9F45-CD6CCB4DCA4D Q26774029-639ACEEC-B79E-46EA-99A5-29F5B8F54232 Q26786667-BF6CDF9A-2331-435D-B34B-52A0514E6391 Q26799916-FB446839-4E67-4AB8-ADF9-4AAE7A24CB36 Q30234692-7F6A1BE6-07B1-432E-9DA5-7D745BD06454 Q30249591-920171BC-4058-4376-BD13-C6BECD1D5E36 Q30277907-85A63C6B-E643-4B9D-AE1F-21A8B5A20486 Q33574617-BD22CE0A-169A-4737-85DA-961058BC9265 Q35806031-CC656E23-09FA-46CA-B0FC-12D292624369 Q36017608-D90CE4E8-DB3A-4D4C-83EC-EB098590FFCD Q36108877-CA08BF5A-C936-49B2-9C13-6A1CB9D5DE95 Q37177497-B3107FE7-7CE5-4CC5-B46A-2C98B2B7C4A2 Q37246209-1A71A569-EC93-4ABA-AB01-FF68049261AA Q37602050-30E6F93B-8967-4A3D-9332-FB12F4C6E5C5 Q37633088-D3092D20-C402-4191-A410-2EFCDC1C8853 Q38285972-C3E80589-A3EA-43E6-B234-F37A0DA8878C Q38665661-4838DA97-A796-4228-B7A9-508EB849A2C6 Q38722803-6DA51336-3E7A-4526-AD46-358E41537EE1 Q38801886-D8055E6B-ACF6-4584-981B-DCC58E370F88 Q38837296-2FE313C9-F6F0-4A14-82E0-8DC2D9DFFA0B Q38874424-E0C50188-2599-4BB6-B35E-4FF9D33AE005 Q38886761-17DAE9F6-EF22-4436-8C62-BB14E1FE1A8B Q39053064-FEDFF51D-7968-4887-ADCB-42068EAB94DB Q39216951-FDE5837B-B954-47E6-A18F-340C7F822EC9 Q39368726-006D4889-C6C1-4DC7-8ADB-314AA1C79A54 Q40259182-5A65D176-35C8-4C58-9661-3229FC3FF17B Q41580179-FB493114-8CF4-4526-8F78-96AA5EFA2C6F Q42362215-C090BBCD-F6F4-453E-B9D0-CEAAA41DFE0B Q45042915-84150FCC-7064-484A-96F6-41E8CAAFA318 Q45057705-89FAF8FD-694F-4481-BA95-03107A6262D3 Q47099369-00BDA047-D575-4487-8D37-500BEC1B2F83 Q47148355-F76B2CC9-83DF-4DB9-8C92-838747D6BC79 Q47256903-6085A152-743E-47D0-9973-F4E5F563B9A8 Q47267273-9BC7D1BC-FCF0-4457-9735-C9F8B0AB673E Q47288967-0CB7F231-6602-49BB-8A59-598DAB7C3C1F Q47360743-74F439D2-7637-4FFB-B97C-128949B84AD9 Q47572943-2794B3A5-4DDB-4FDA-82D3-B93671A817F8 Q47994195-1685BF34-379C-4996-BB06-B1107572A1FF

P2860

Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications.

http://www.wikidata.org/entity/Q34828809

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Biomarkers of AKI: a review of ...... tial therapeutic implications.

@ast

Biomarkers of AKI: a review of ...... tial therapeutic implications.

@en

Biomarkers of AKI: a review of ...... tial therapeutic implications.

@nl

type

label

Biomarkers of AKI: a review of ...... tial therapeutic implications.

@ast

Biomarkers of AKI: a review of ...... tial therapeutic implications.

@en

Biomarkers of AKI: a review of ...... tial therapeutic implications.

@nl

prefLabel

Biomarkers of AKI: a review of ...... tial therapeutic implications.

@ast

Biomarkers of AKI: a review of ...... tial therapeutic implications.

@en

Biomarkers of AKI: a review of ...... tial therapeutic implications.

@nl

P1433

Q34828809-96264417-7A80-4642-B326-487E79332E4D

P1476

Q34828809-458D8E81-986D-40DF-AD12-B096E68B8FAF

P2093

Q34828809-2A9F6626-3785-400C-9C90-B5BD4B2C2E79

Q34828809-932598B5-3747-477F-B453-B3E8FF60DF57

P2860

Q34828809-00D304F7-7963-42FE-8EB2-7F90A1999FEA

Q34828809-024B9B5B-8FC7-442C-899E-01982798B28D

Q34828809-0675692B-CF04-428A-9C39-DEE36C5C055A

Q34828809-0C0AA7A6-11BB-42DC-B142-1836EAF7544B

Q34828809-0FF42D37-BD61-4D36-9441-14352AA49F6D

Q34828809-10BE01B5-A80B-40B3-A078-FDB2984EAA7D

Q34828809-1781D327-A5AB-4E0D-B25E-19D803D374E1

Q34828809-1DCF24A6-6959-4C43-A387-B7061A2781B2

Q34828809-1E810BEC-6C31-4998-B4EF-28C09CE14EF4

Q34828809-2234D44E-E915-4705-810C-135A38F50E5B

P304

Q34828809-6A99F24F-2E66-4D9A-8EB1-A1E964B045CA

P31

Q34828809-4D70E055-ED74-4430-889D-608644310229

P356

Q34828809-AC98104F-8146-43FE-AAF8-99A275DFA086

P433

Q34828809-1A14C565-5292-4B1F-B219-A5C2B33F374A

P478

Q34828809-9F2F3C27-4A62-49E5-8C23-1C762F80A50A

P50

Q34828809-8EE7F161-E087-4463-B752-213BD14E3B8F

Q34828809-EDC4ECE7-82F0-4830-A001-7FFF65222592

P577

Q34828809-0A04633E-C1FA-4B5B-8E78-EEA5D0912EE5

P698

Q34828809-5556EA63-B5B0-4E11-B9BF-0B101A624F17

P921

Q34828809-12EEA0D7-FABD-4F2A-84F7-6A473E2263AB

P932

Q34828809-00CC88A6-A049-4FFF-8317-CA3B161D12D8

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Biomarkers of AKI: a review of ...... tial therapeutic implications.

@en

P2093

John M Arthur

http://www.w3.org/2001/XMLSchema#string

Joseph L Alge

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response

Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells

Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells

The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition

Iron traffics in circulation bound to a siderocalin (Ngal)–catechol complex

Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration

An iron delivery pathway mediated by a lipocalin

Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure

Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells

The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake

P304

147-155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.12191213

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25092601

http://www.w3.org/2001/XMLSchema#string

P921

P932

4284423

http://www.w3.org/2001/XMLSchema#string